Oral Ketorolac for Arthroscopic Rotator Cuff Repair

University Hospitals (UH)

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain; Rotator Cuff Tear

Treatments: Drug: Ketorolac

Study type: Interventional

Funder types: Other

Identifiers

NCT03967847

20180949

Details and patient eligibility

About

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair.
2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

Enrollment: 44 patients

Sex: All

Ages: 18 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

1. Patients between the ages of 18 and 89 years old, male or female
2. Patients undergoing primary shoulder arthroscopic rotator cuff repair

Exclusion Criteria

1. Patients below the age of 18 or above the age of 89
2. Illiterate or non-English speaking patients
3. Patients with contraindications to Ketorolac
4. History of alcohol of drug abuse
5. Chronic use of analgesic or psychotropic drugs
6. Known peptic ulcer disease or bleeding diathesis
7. Renal dysfunction

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

44 participants in 2 patient groups

Control

No Intervention group

Ketorolac

Experimental group

Treatment:

Drug: Ketorolac